BIOTTS, a Polish-American biotech company, develops proprietary drugs in oncology, diabetology and pain utilizing unique formulations and drug delivery technologies.
Biotts scientists have developed a breakthrough technology of universal transdermal therapeutic system MTC-Y (Multifunctional Transdermal Carrier-Y). The properties of the carrier increase the bioavailability of active substances several times, enabling them to penetrate through the skin into soft tissues and bones. The carrier can be easily modified to obtain targeted action in pathologically changed tissues. Thanks to the system, it is possible to reduce the therapeutic dose of the drug while maintaining its original effect and simultaneously reducing the side effects. In addition, the system enables the transport of one to several active substances, which makes it possible to design multi-component drugs.
Company Details
- Employees
- 19
- Founded
- -
- Address
- Wrocławska,
- of****@****tts.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- biotts.com
- Keywords
- Wrocław.
- HQ
- Bielany Wrocławskie, Dolnośląskie
Biotts Questions
Biotts's website is biotts.com
Biotts's LinkedIn profile is https://www.linkedin.com/company/biotts
Biotts has
19 employees.
View email and phone details for 19
employees at Biotts.
Biotts's industry is
Pharmaceutical Manufacturing
Biotts's top competitors are
Genomtec Sa,
Molecure,
Bioceltix,
Pure Biologics,
Genxone S.a.,
Selvita,
Ardigen,
Ryvu Therapeutics,
Captor Therapeutics Sa,
Bioton S.a..
Biotts's support email address is office@biotts.com
Biotts's categories are Pharmaceutical Manufacturing
Biotts's founding year is 2018
